PubRank

Eva van Rooij

Author PubWeight™ 47.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010 3.72
2 Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010 3.04
3 MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009 3.04
4 Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011 2.52
5 MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res 2011 2.32
6 A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 2012 2.29
7 The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest 2008 2.24
8 Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 2011 2.02
9 Regulation of cardiac stress signaling by protein kinase d1. Mol Cell Biol 2006 2.01
10 MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. J Clin Invest 2012 1.90
11 MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 2006 1.80
12 A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res 2012 1.61
13 Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. Mol Cell Biol 2005 1.47
14 Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc Natl Acad Sci U S A 2007 1.42
15 Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proc Natl Acad Sci U S A 2006 1.40
16 Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation 2013 1.31
17 Searching for miR-acles in cardiac fibrosis. Circ Res 2009 1.19
18 Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction. Proc Natl Acad Sci U S A 2007 1.10
19 Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail 2013 1.09
20 Calcineurin and hypertrophic heart disease: novel insights and remaining questions. Cardiovasc Res 2002 1.00
21 Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice. Cardiovasc Res 2005 1.00
22 MicroRNA regulation as a therapeutic strategy for cardiovascular disease. Curr Drug Targets 2010 1.00
23 MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc Nephrol 2013 0.99
24 miRNAs as therapeutic targets in ischemic heart disease. J Cardiovasc Transl Res 2010 0.99
25 Therapeutic advances in MicroRNA targeting. J Cardiovasc Pharmacol 2011 0.98
26 Regulated expression of pH sensing G Protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. ACS Chem Biol 2012 0.95
27 miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. Eur Heart J 2013 0.95
28 Cardiac Repair after Myocardial Infarction. N Engl J Med 2016 0.80
29 Circulating microRNAs to identify human heart failure. Eur J Heart Fail 2012 0.80
30 miRNA overexpression induces cardiomyocyte proliferation in vivo. Mol Ther 2013 0.79
31 Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research. Eur J Heart Fail 2013 0.75